客户端
食品晚九点
国际食品
最新搜索:
 
 
当前位置: 首页 » 食品资讯 » 外讯导读 » 欧盟评估葡糖基橙皮苷作为新型食品的安全性

欧盟评估葡糖基橙皮苷作为新型食品的安全性

放大字体  缩小字体 时间:2024-08-09 10:07 来源:食品伙伴网 作者: 泽夕   
核心提示:2024年8月8日,据欧盟食品安全局(EFSA)消息,欧盟营养、新型食品和食物过敏原(NDA)研究小组就葡糖基橙皮苷(glucosyl hesperidin)作为新型食品的安全性发表科学意见。
   食品伙伴网讯  2024年8月8日,据欧盟食品安全局EFSA)消息,欧盟营养、新型食品和食物过敏原(NDA)研究小组就葡糖基橙皮苷(glucosyl hesperidin)作为新型食品的安全性发表科学意见。
 
  经过评估,专家小组得出结论,在提议的使用条件下,葡糖基橙皮苷作为新型食品是安全的。部分原文报道如下:
 
  Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on glucosyl hesperidin (GH) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF, which is produced from hesperidin and dextrin by enzymatic reactions, is a powder consisting mainly of monoglucosyl hesperidin (MGH) and unreacted hesperidin (flavonoid), which account in total for up to 92.8% (on dry basis) of the product. The applicant proposed to use the NF in specific drinks and food supplements leading to a maximum intake of up to 364 mg per day for adults. The target population is the general population, except for food supplements for which the proposed target population is children from 1 year onwards and adults. Taking into consideration the composition of the NF and the proposed uses, the consumption of the NF is not nutritionally disadvantageous. There are no concerns regarding genotoxicity of the NF. based on a 90-day oral toxicity study conducted with the NF, the Panel considers the NOAEL at the mid-dose group, i.e. ~ 1000 mg/kg body weight (bw) per day. By applying an uncertainty factor of 200, the resulting intake providing sufficient margin of exposure for humans would be 5 mg/kg bw per day. The available human intervention studies did not report clinically relevant changes in haematological or clinical chemistry parameters following the administration of GH/MGH at supplemental doses of up to 3 g/day for 12 weeks. Overall, the Panel considers that the margin of exposure (~ 200) between the intake of the NF at the proposed uses and use levels and the NOAEL from the 90-day study is sufficient. The Panel concludes that the NF, glucosyl hesperidin, is safe for the target population at the proposed uses and use levels.
 
  本文由食品伙伴网食品资讯中心编辑,供网友参考,有任何疑问,请联系news@www.sqrdapp.com。
日期:2024-08-09
 
 
[ 食品资讯搜索 ]  [ 加入收藏 ]  [ 告诉好友 ]  [ 打印本文 ]  [ 关闭窗口 ]

 

 
 
行业相关食品资讯
 
地区相关食品资讯
会展动态MORE +
 
推荐图文
按字母检索 A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
食品伙伴网资讯部  电话:0535-2122172  传真:0535-2129828   邮箱:news@www.sqrdapp.com   QQ:点击这里给我发消息
鲁公网安备 37060202000128号
 
Baidu
map